Caxton Associates (UK)’s Corteva CTVA Stock Holding History

Caxton Associates (UK)’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,198	Closed	-$387K	–	751
2025 Q2	$387K	Buy	+5,198	New	+$346K	0.01%	485

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Caxton Associates (UK)'s CTVA Position: Q3 2025 in Review

Caxton Associates (UK) sold out of Corteva (CTVA) in Q3 2025, closing a stake of 5,198 shares — an estimated $387K sold.

Caxton Associates (UK) first reported a position in CTVA in Q2 2025 and held it in 1 quarter. The position peaked at $387K in Q2 2025. 1,394 funds tracked by Wall St. Rank hold CTVA as of Q3 2025.

Caxton Associates (UK) reported no remaining Corteva position as of Q3 2025 after selling out during the quarter.
Caxton Associates (UK) sold 5,198 Corteva shares in Q3 2025, an estimated $387K.
Caxton Associates (UK) first reported a position in Corteva in Q2 2025 and held it in 1 quarter.
Caxton Associates (UK)'s Corteva position peaked at $387K in Q2 2025.
1,394 funds tracked by Wall St. Rank held Corteva as of Q3 2025.

Based on Caxton Associates (UK)'s 13F filing for Q3 2025, filed 17 Nov 2025.